The Prevalence of Hearing Loss in Patients with Hepatitis B Infection Compared with Healthy Volunteers
- PMID: 28589105
- PMCID: PMC5448026
The Prevalence of Hearing Loss in Patients with Hepatitis B Infection Compared with Healthy Volunteers
Abstract
Introduction: Hepatitis B virus is a virus that creates significant hepatic and extra-hepatic complications, with widespread prevalence across the community and body systemic involvement, and can impact on hearing performance. This study aims to evaluate hearing loss among individuals with hepatitis B compared with healthy subjects.
Materials and methods: In this case-control study, 83 HBsAg-positive patients with a 1-year history of disease were selected for pure tone audiometry (PTA) testing, while 108 HBsAg-negative patients were selected as the control group. Subjects in both groups were aged 20-40 years. The threshold was set at 25 db for hearing loss. Final data were analyzed using SPSS software.
Results: Significant differences were found between the case group and control group in average PTA and hearing loss. There was also a significant difference between the two groups in average PTA at frequencies of 250, 4,000, and 8,000 Hz, but not at speech frequencies of 500, 1,000 and 2,000 Hz, despite the difference in average PTA.
Conclusion: According to significant differences in average PTA between patients with hepatitis B virus and healthy subjects in this study, hearing loss may be attributed to the presence HBV of in the patient group.
Keywords: Audiometry; Healthy volunteers; Hearing loss; Hepatitis B infection.
Similar articles
-
Otitis media with effusion in children: Cross-frequency correlation in pure tone audiometry.PLoS One. 2019 Aug 22;14(8):e0221405. doi: 10.1371/journal.pone.0221405. eCollection 2019. PLoS One. 2019. PMID: 31437206 Free PMC article.
-
A comparison of conventional and in-situ audiometry on participants with varying levels of sensorineural hearing loss.J Am Acad Audiol. 2015 Jan;26(1):68-79. doi: 10.3766/jaaa.26.1.8. J Am Acad Audiol. 2015. PMID: 25597462 Clinical Trial.
-
Intratympanic dexamethasone for sudden sensorineural hearing loss after failure of systemic therapy.Laryngoscope. 2007 Jan;117(1):3-15. doi: 10.1097/01.mlg.0000245058.11866.15. Laryngoscope. 2007. PMID: 17202923 Review.
-
Association between hepatitis B and hearing status.Oman Med J. 2012 Sep;27(5):418-20. doi: 10.5001/omj.2012.103. Oman Med J. 2012. PMID: 23074556 Free PMC article.
-
[Hearing Loss and Speech Recognition in the Elderly].Laryngorhinootologie. 2017 Nov;96(11):759-764. doi: 10.1055/s-0043-119388. Epub 2017 Nov 13. Laryngorhinootologie. 2017. PMID: 29132188 Review. German.
Cited by
-
The Pathogenesis of Cytomegalovirus and Other Viruses Associated with Hearing Loss: Recent Updates.Viruses. 2023 Jun 16;15(6):1385. doi: 10.3390/v15061385. Viruses. 2023. PMID: 37376684 Free PMC article. Review.
-
Role of Inner Ear Macrophages and Autoimmune/Autoinflammatory Mechanisms in the Pathophysiology of Inner Ear Disease.Front Neurol. 2022 Apr 6;13:861992. doi: 10.3389/fneur.2022.861992. eCollection 2022. Front Neurol. 2022. PMID: 35463143 Free PMC article. Review.
References
-
- Locarnini S, Hatzakis A, Chen DS, Lok A. Strategies to control hepatitis B: Public policy, epidemiology, vaccine and drugs. J Hepatol. 2015;62(1):76–86. - PubMed
-
- Alter SJ, Bennett JS, Koranyi K, Krepple A, Simon R. Common Childhood Viral Infections. Curr Probl Pediatr Adolesc Health Care. 2015;45(2):21–53. - PubMed
LinkOut - more resources
Full Text Sources
Miscellaneous